11 results on '"Heinzmann D"'
Search Results
2. Simultaneous unbiased and absolute quantification of a 500 protein panel in pancreatic cancer plasma using HRM mass spectrometry
3. Subcutaneous trastuzumab (H SC) with intravenous pertuzumab (P IV) and docetaxel (D IV) in HER2-positive advanced breast cancer (BC): MetaPHER second interim analysis
4. 579P Methodological considerations for clinical equivalence of bevacizumab biosimilars
5. P201 Subcutaneous versus intravenous trastuzumab in early breast cancer: 2-year follow-up of HannaH
6. P103 Subcutaneous trastuzumab plus chemotherapy for early breast cancer: interim safety from SafeHer
7. Trastuzumab Retreatment after Relapse on Adjuvant Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Final Results of the Retreatment after Herceptin Adjuvant Trial
8. Comparative Pharmacokinetics of Trastuzumab Subcutaneous Formulation Administered Using a Proprietary Single-Use Injection Device, or Manually Using a Syringe
9. Additional Safety Results of Hannah: A Phase III Randomised, Open-Label, International Study of the Subcutaneous Formulation of Trastuzumab (H) in HER2-Positive Early Breast Cancer Patients
10. Immunogenicity of Trastuzumab Intravenous and Subcutaneous Formulations in the Phase III Hannah Study
11. 1BA Subcutaneous Administration of Trastuzumab in Patients with HER2-positive Early Breast Cancer: Results From the Phase III Randomised, Open-label, Multi-centre Neoadjuvant-adjuvant HannaH Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.